If you’ve been diagnosed with sleep apnea, it means your breathing gets shallow or even stops and restarts while you’re asleep. Often, the first treatment your doctor may have you try is a device to ...
-- The Simple, No-cost Test Can Detect Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Autoantibodies in the Blood with Only a Finger Prick -- The DBS test demonstrates a high correlation ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, recently launched aPAP ClearPath™, a new ...
LANGHORNE, Pa., October 22, 2024--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that a new ...
Oppenheimer raised the firm’s price target on Savara (SVRA) to $8 from $6 and keeps an Outperform rating on the shares following updated analysis pointing to 5,500 aPAP patients in the U.S. from ...